Tough transplant cases? Hospital up to the task
Dane Conrads, now almost 4, was “desperately ill” when he received his liver transplant in 2014. Last year, he also benefited from one of the most complicated kidney transplants ever performed at Packard Children’s Hospital.
Integrated strategic plan unveiled at town hall
More than 400 faculty, staff and students assembled March 23 to hear Stanford Medicine leaders lay out the principles of an integrated strategic plan aimed at aligning the goals and priorities of the medical school and hospitals.
Taubes commit $20 million to children’s hospital
The new hospital’s south pavilion will be named in honor of Bay Area philanthropists Tad and Dianne Taube.
Physicians discuss gun violence
Gun violence is a public-health problem that physicians may be able to help alleviate by conducting research and educating patients about gun safety, said experts at a recent teach-in on campus.
CEO of Packard Children’s to retire
Christopher Dawes, who oversaw the development of Stanford Medicine’s pediatric health network and Lucile Packard Children’s Hospital Stanford, announced his retirement on March 20.
Graduating med students meet their matches
Stanford medical students gathered together on Match Day to find out where they would serve their residencies for the next three or more years.
Neuroanatomy lab bridges virtual reality, OR
Stanford’s Department of Neurosurgery has a new anatomy lab next door to its virtual reality center. Together, the labs are a valuable resource for trainees and surgeons alike.
Exome sequencing program launched
The Clinical Genomics Program, which began as a pilot program a few years ago, offers whole-exome sequencing and analysis to patients with undiagnosed genetic diseases.
Medicare’s blame game
A Stanford researcher and his colleague got access to data showing the inner workings of an influential committee advising Medicare. They found that bias among its members has different effects from what critics claim.
Antibody treatment for ‘bubble boy’ disease
In a clinical trial, participants were given an antibody to CD117, a cell surface marker, in an effort to wipe out their defective blood stem cells without high-risk chemotherapy or radiation.
Leading in Precision Health
Stanford Medicine is leading the biomedical revolution in precision health, defining and developing the next generation of care that is proactive, predictive and precise.
A Legacy of Innovation
Stanford Medicine's unrivaled atmosphere of breakthrough thinking and interdisciplinary collaboration has fueled a long history of achievements.